Soleus Capital Management, L.P. - IMMUNIC INC ownership

IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 65 filers reported holding IMMUNIC INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of IMMUNIC INC
ValueSharesWeighting
Q3 2023$441,000
-41.4%
300,0000.0%0.04%
-51.2%
Q2 2023$753,000
+68.5%
300,0000.0%0.08%
+82.6%
Q1 2023$447,000
-41.0%
300,000
+25.0%
0.05%
-55.3%
Q3 2022$758,000
-9.0%
240,0000.0%0.10%
-20.8%
Q2 2022$833,000
-69.3%
240,0000.0%0.13%
-62.9%
Q1 2022$2,712,000
+61.9%
240,000
+37.1%
0.35%
+108.3%
Q4 2021$1,675,000175,0000.17%
Other shareholders
IMMUNIC INC shareholders Q4 2022
NameSharesValueWeighting ↓
AWH Capital, L.P. 1,000,000$1,400,0000.88%
Omega Fund Management, LLC 1,788,160$2,503,4240.84%
COMMODORE CAPITAL LP 1,800,000$2,5200.38%
Ikarian Capital, LLC 650,000$910,0000.22%
Gratus Capital, LLC 1,668,294$2,335,6120.19%
GREAT POINT PARTNERS LLC 632,184$885,0580.17%
Parkman Healthcare Partners LLC 459,770$643,6780.17%
Anson Funds Management LP 664,935$930,9090.15%
SILVERARC CAPITAL MANAGEMENT, LLC 350,656$490,9180.14%
COWEN AND COMPANY, LLC 791,024$1,107,4330.12%
View complete list of IMMUNIC INC shareholders